期刊文献+

多次利培酮治疗致抗精神病药恶性综合征 被引量:5

Neuroleptic malignant syndrome after repeated treatment with risperidone
原文传递
导出
摘要 1例31岁女性患者因精神分裂症给予利培酮1 mg,2次/d口服,1周后剂量增至2 mg,2次/d。此前患者曾3次间断应用利培酮治疗。本次治疗规律服药49 d,患者精神症状缓解。第50~52天未遵医嘱规律服药。第54天患者出现大汗淋漓,体温达38.5℃。第55天出现意识障碍、心动过速、双上肢肌强直、肌张力增高。心电图示窦性心动过速。实验室检查示:白细胞计数12.3×109/L,胆碱酯酶13 268 U/L,肌酸激酶1447 U/L,利培酮血液浓度70.5μg/L。诊断为抗精神病药恶性综合征(NMS)。立即停用利培酮,进行物理降温、补液、抗心律失常、抗感染、纠正酸碱平衡、护肝等治疗。6 d后患者体温恢复正常,NMS症状消失。换用奥氮平治疗后,未再出现类似症状。 A 31-year-old woman with schizophrenia received risperidone 1 mg twice daily. One week later, the dose was increased to 2 mg twice daily. The patient had previously received risperidone intermittent treatment for three times. After a 49-day regular treatment, the psychiatric symptoms relieved. On days 50 to 52, she did not adhere to the instructions of the physician for regular use of the drug. On day 54, the patient experienced profuse sweating with a temperature of 38.5 ℃. On day 55, she developed disturbance of consciousness, tachycardia, muscle rigidity of the upper limbs, and hypermyotonia. Her electrocardiograph showed sinus tachycardia. Laboratory tests showed the following findings: white blood cell count 12.3 × 109/L, cholinesterase 13 268 U/L, creatine kinase 1447 U/L. The blood concentrations of risperidone was 70.5 μg/L. Neuroleptic malignant syndrome (NMS) was diagnosed. The medication was stopped immediately. Physical methods for lowering body temperature, fluid supplement, antiarrhythmics, anti- infective therapy, correction of the acid-base imbalance, and liver-protective treatment were given. Six days later, the temperature returned to normal, the NMS symptoms disappeared. After switch to olanzapine therapy, the similar symptoms did not recur.
出处 《药物不良反应杂志》 2012年第2期111-113,共3页 Adverse Drug Reactions Journal
关键词 抗精神病药恶性综合征 利培酮 neuroleptic malignant syndrome risperidone
  • 相关文献

参考文献11

  • 1Tsai HC, Kuo PH, Yang PC. Fever, consciousness disturbance, and muscle rigidity in a 68-year-old man with depressive disorder [J]. Chest, 2003, 124(4) :1598-1601.
  • 2Chandran GJ, Mikler JR, Keeqan DL. Neuroleptie malignant syndrome: ease report and discussion [ J ]. CMAJ, 2003, 169 (5) : 439-442.
  • 3Mann SC, Caroff SN, Fricchione G, et al. Central dopamine hypoactivity and the pathogenesis of neuroleptie malignant syndrome [J]. Psychiatr Ann, 2000, 30: 363-374.
  • 4Addonizio G, Susman VL, Roth SD. Symptoms of neuroleptie malignant syndrome in 82 consecutive inpatients[ J]. Am J Psychiatry, 1986, 143(12): 1587-1590.
  • 5Woodbury MM, Woodbury MA. Neuroleptic-induced eatatonia as a stage in the progression toward neuroleptic malignant syndrome [J]. J Am Acad Child Adolesc Psychiatry, 1992, 31(6) : 1161- 1164.
  • 6王悦,崔丽英.恶性神经抑制综合征[J].中国实用内科杂志,2010,30(10):934-935. 被引量:3
  • 7刘玉兰,田峰.利培酮口服液(单克)致恶性综合征1例报道[J].中国民康医学,2011,23(21):2739-2739. 被引量:1
  • 8冉小平,刘碧明,艾池波.利培酮片致恶性综合征1例[J].重庆医学,2009,38(12):1442-1442. 被引量:1
  • 9杨林.利培酮口服液致恶性综合征1例[J].大理学院学报(综合版),2007,6(4):89-89. 被引量:7
  • 10隋忠庆,徐作国.利培酮致恶性症状群一例[J].精神医学杂志,2008,21(4):305-305. 被引量:2

二级参考文献19

  • 1赵彬,高志勤,余海鹰,吴群安,蒋军生,徐鹏,谢国军,王少娟,朱素凡,陈福新,赵仁珍,杨惠云,本刊编辑部.精神药物的不良反应及戒断反应[J].临床精神医学杂志,2005,15(5):317-318. 被引量:6
  • 2Tsai HC, Kuo PH, Yang PC. Fever, consciousness disturbance,and muscle rigidity in a 68 years old man wan with depressive disorder[J]. Chest, 2003,124(4):1598.
  • 3Chandran GJ, Mikler JR, Keeqan DL. Neurolep ticmalignantsyndrome: case report and discussion [J]. CMAJ, 2003,169(5):439.
  • 4Delay J, Pichot P, Lemperiere T,et al. Un neuroleptique majeur non-phenothiazine et nonreserpinique, l'haloperidol, dans le traitement des psychoses [ J ]. Annales Medico-Psychologique, 1960, 118:145 - 152.
  • 5Stubner S, Rustenbeck E, Grohmann R, et al. Severe and uncommon involuntary movement disorders due to psychotropic drugs [ J ]. Pharmacopsychiatry ,2004,37 ( suppl 1 ) : S54 - S64.
  • 6Mann SC,Caroff SN, Fricchione G, et al. Central dopamine hypoactivity and the pathogenesis of the neuroleptic malignant syndrome [ J ]. Psychiatr Ann,2000,30:363 - 374.
  • 7Jambur A,Kamala A,Sharath P, et al. Neuroleptic malignant syndrome : risk factors, pathophysiology, and trealment [ J ]. Acta Neuropsychiatrica,2004,16 : 219 - 228.
  • 8Caroff SN,Mann SC, Lazarus A,et al. Neuroleptic malignant syndrome:diagnostic issues[J]. Psychiatric Ann,1991,21:130 - 147.
  • 9Bhanushali MJ,Tuite PJ. The evaluation and management of patients with neuroleptic malignant syndrome[ J ]. Neurol Clin,2004, 22(2) :389 -411.
  • 10Caroff SN, Mann SC. Neuroleptic malignant syndrome[ J ]. Psychopharmacol Bull, 1988,24:25 - 29.

共引文献9

同被引文献49

引证文献5

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部